Your browser doesn't support javascript.
loading
Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?
Huang, Joanne; Winkler, Marisa L; Monk, Miranda; Letourneau, Alyssa R; Elshaboury, Ramy H.
Afiliação
  • Huang J; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA; Department of Pharmacy, UW Medicine, Valley Medical Center, Renton, WA, USA. Electronic address: joanne_huang@valleymed.org.
  • Winkler ML; Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
  • Monk M; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
  • Letourneau AR; Department of Medicine, Harvard Medical School, Boston, MA, USA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Elshaboury RH; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
Int J Antimicrob Agents ; 62(3): 106912, 2023 09.
Article em En | MEDLINE | ID: mdl-37419293

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftriaxona / Sepse Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftriaxona / Sepse Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article